To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: DBV, Beam, Aeon Biopharma

DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) said Deputy CEO and Principal Financial Officer David Schilansky will leave the company in August to pursue other opportunities. The allergy company is searching for a new CFO but will not fill the deputy CEO position.

Beam Therapeutics (Cambridge, Mass.) hired Christine Bellon as

Read the full 482 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers